• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: October 20-24, 2008

 

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

FDA Official and Title Date Location Other FDA Participants Non-FDA Participants Subject
Andrew von Eschenbach, Commissioner, Food and Drugs 10/21/08 Boston, MA Ginny Gunderson N/A Speech at the Harvard Medical School Lecture Series on “Advancing Healthcare Reform: Perspectives on our Trajectory Toward Change
Andrew von Eschenbach, Commissioner, Food and Drugs 10/24/08 Chantilly, VA Ginny Gunderson N/A Speech at the 2008 Mid-Atlantic Bio and Investor Conference
Frank Torti, Principal Deputy Commissioner and Chief Scientist, Food and Drugs 10/20/08 through 10/24/08 N/A N/A N/A No significant meetings
John Dyer, Deputy Commissioner for Operations and Chief Operating Officer 10/20/08 through 10/24/08 N/A N/A N/A No significant meetings
Murray Lumpkin, Deputy Commissioner for International and Special Programs 10/20/08 through 10/24/08 N/A N/A N/A No significant meetings
Randall Lutter, Deputy Commissioner for Policy 10/22/08 Rockville, Maryland Ilisa Bernstein, David Horowitz, Irene Chan, Nancy Ostrove Ladd Wiley, (Akin Gump Strauss Hauer & Feld LLP), Marcie Bough, (Amer. Pharmacists Assn.,) Claire DeMatteis, (Catalina Health Resource), Rick Frank, Olsson Frank Weeda, Mimi Johnson, (National Consumers League), Julie Khanie, (National Assn. of Chain Drugstores), Tony Lee, (National Community Pharmacists Assn.), Cathy Polley, (Food Marketing Institute) In-Pharmacy Communication/Single Document Solution
Janet Woodcock, Director, Center for Drug Evaluation and Research 10/20/08 Bethesda North Marriott Hotel Steven Kozlowski, Gary Buehler, Christine Moore Dennis Bell, Cary Smithson Annual CDER on CMC
Janet Woodcock, Director, Center for Drug Evaluation and Research 10/23/08 Mount Sinai School of Medicine, New York N/A Stephen Burley, Garret FitzGerald, Zahi Fayad Enabling New Therapeutics 
Janet Woodcock, Director, Center for Drug Evaluation and Research 10/24/08 Washington DC Norman Stockbridge, Melanie Blank, Mark Avigan  Paul Watkins, Dan Bloomfield, Robert Star Safety Biomarkers Workshop
Michael Chappell, Acting Associate Commissioner, Office of Regulatory Affairs 10/20/08 through 10/24/08 N/A N/A N/A No significant meetings
Jesse Goodman, Director, Center for Biologics Evaluation and Research 10/21/08 Rockville, MD N/A N/A Meeting with representatives of the Alliance of Blood Operators
Jesse Goodman, Director, Center for Biologics Evaluation and Research 10/22/08 Washington, DC N/A N/A Obvervational Medical Outcomes Pilot Executive Board Meeting
Daniel Schultz, Director, Center for Devices and Radiological Health 10/24/08 St. Helena, CA N/A N/A Speech at Accuitive Medical Ventures Conference
Stephen Sundlof, Center for Food Safety and Applied Nutrition 10/22/08 College Park, MD Michael Landa, Nega Beru, Robert Childers, John Sheehan, Robert Moore, Mary Poos, Geraldine June, Felicia Billingslea, Nancy Yanish Jerry Kozak, National Milk Producers Federation (NMPF), Robert Byrne, NMPF  Labeling of  Soy  Milk
Bernadette Dunham, Director, Center for Veterinary Medicine 10/22-23/08 Dana Point, CA N/A N/A Speech at National Renderers Association 75th Annual Convention
William Slikker, Director, National Center for Toxicological Research 10/18-22/08 Rio Grande, Puerto Rico N/A N/A Presentation on methylphendiate at the 39th Annual Meeting of the Environmental Mutagen Society
Gerald Masoudi, Chief Counsel 10/20/08 Rockville, MD Elizabeth Dickinson, Jeffrey Senger Carolyn Hathaway, Philip Perry, John Manthei (Latham & Watkins) Generic Drug Approval Issue
Gerald Masoudi, Chief Counsel 10/24/08 Rockville, MD Lynn Whipkey-Mehler Neal Parker (Abbott), David M. Fox (Hogan & Hartson) Abbott Aproval Issues